Showing 761-770 of 1555 results for "".
Navigating Challenges and Embracing Opportunities
https://modernod.com/topics/business/navigating-challenges-and-embracing-opportunities/38841/Optic Nerve Hemorrhages and Glaucoma
https://modernod.com/topics/glaucoma/optic-nerve-hemorrhages-and-glaucoma/38517/Sometimes learning from our predecessors can be just as important as keeping up with the latest trends.Cataract Surgery
https://modernod.com/topics/business/cataract-surgery/38134/Diabetic Retinopathy
https://modernod.com/topics/retina/diabetic-retinopathy/38133/The Pink Eye
https://modernod.com/mod-issues/2019-june/the-pink-eye/39065/Introduction to Holistic Optometry
https://modernod.com/topics/nutritionpharmaceuticals/introduction-to-holistic-optometry/38607/Hear from several colleagues who specialize in this increasingly popular health care praxis.What Are Those Online Retailers Up To?
https://modernod.com/topics/contact-lenses/what-are-those-online-retailers-up-to/37930/And what’s being done to try to level the playing field in contact lenses?The Role of the Optometrist in the Evolving Management of Diabetic Retinopathy
https://modernod.com/mod-issues/supplements-inserts/the-role-of-the-optometrist-in-the-evolving-management-of-diabetic-retinopathy/38139/49. IRPL Technology with I-MED Pharma: Part One
https://modernod.com/podcasts/four-eyes/49-irpl-technology-with-i-med-pharma-part-one/36999/This episode is sponsored by I-MED PHARMA.I-MED Pharma is a Canadian company specializing in dry eye diagnosis and management since 1989. I-MED Pharma provides innovative ocular surface disease solutions to Canadian optometrists, ophthalmologists, and the global eye care community. The company has aTreating Ocular Surface Disease With Scleral Lenses
https://modernod.com/topics/contact-lenses/treating-ocular-surface-disease-withscleral-lenses/37927/These lenses can benefit patients with dry eye and other ocular surface diseases for whom alternative treatment options have been ineffective.